MY7800381A - Dopamine derivatives - Google Patents

Dopamine derivatives

Info

Publication number
MY7800381A
MY7800381A MY381/78A MY7800381A MY7800381A MY 7800381 A MY7800381 A MY 7800381A MY 381/78 A MY381/78 A MY 381/78A MY 7800381 A MY7800381 A MY 7800381A MY 7800381 A MY7800381 A MY 7800381A
Authority
MY
Malaysia
Prior art keywords
dopamine derivatives
dopamine
derivatives
Prior art date
Application number
MY381/78A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY7800381(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY7800381A publication Critical patent/MY7800381A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY381/78A 1972-04-12 1978-12-30 Dopamine derivatives MY7800381A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
MY7800381A true MY7800381A (en) 1978-12-31

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
MY381/78A MY7800381A (en) 1972-04-12 1978-12-30 Dopamine derivatives

Country Status (31)

Country Link
JP (2) JPS5825656B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR790000113B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR203822A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT323719B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU472734B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE798051A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG23001A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1018188A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH580563A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (2) CS190406B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY963A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD107670B3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2317710C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK142750C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES413639A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2182947B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1392674A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK50178A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU166213B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE37511B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL42016A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KE (1) KE2870A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY7800381A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL174459C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH11041A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL94207B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (2) RO70892A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE399064B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU496719A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (2) YU36483B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA732136B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
KR840000486A (ko) * 1981-07-22 1984-02-22 원본미기재 치환된 피롤리딘의 제조방법
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
AU2005225239B2 (en) 2002-10-03 2012-06-14 Novaremed Ltd Compounds for treating AIDS and other diseases
SI1546088T1 (sl) 2002-10-03 2015-04-30 Novaremed Ltd. Spojine za uporabo v zdravljenju avtoimunskih bolezni, imunoalergijskih bolezni in zavrnitve transpalantata organa ali tkiva
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
RU2012107457A (ru) 2009-07-31 2013-09-10 Когнишн Терапьютикс, Инк. Ингибиторы ухудшения когнитивных способностей
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
WO2013029057A2 (en) * 2011-08-25 2013-02-28 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
KR102331422B1 (ko) 2014-01-31 2021-11-25 카그니션 테라퓨틱스, 인코퍼레이티드 아이소인돌린 조성물 및 신경퇴행성 질환을 치료하는 방법
WO2018213281A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实(湖南)医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
CH569691A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-28
SU496719A3 (ru) 1975-12-25
AU472734B2 (en) 1976-06-03
KR790000113B1 (en) 1979-03-20
FR2182947A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-14
GB1392674A (en) 1975-04-30
KE2870A (en) 1978-09-01
HK50178A (en) 1978-09-15
YU37113B (en) 1984-08-31
PH11041A (en) 1977-10-25
NL174459C (nl) 1984-06-18
YU36483B (en) 1984-02-29
PL90695B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-01-31
NL7305097A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-10-16
JPS5825656B2 (ja) 1983-05-28
HU167597B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-28
YU97673A (en) 1982-02-25
PL94207B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-07-30
RO65105A (ro) 1980-01-15
DK142750B (da) 1981-01-12
DD107670B3 (de) 1988-04-06
DD107670A5 (de) 1974-08-12
AU5438573A (en) 1974-10-17
HU166213B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-02-28
CY963A (en) 1978-12-22
BG23001A3 (bg) 1977-05-20
CA1018188A (en) 1977-09-27
CS190448B2 (en) 1979-05-31
JPS58131945A (ja) 1983-08-06
NL174459B (nl) 1984-01-16
AT323719B (de) 1975-07-25
JPS6221343B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-05-12
IL42016A (en) 1976-05-31
AR203822A1 (es) 1975-10-31
CH580563A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-10-15
ZA732136B (en) 1974-03-27
DE2317710C2 (de) 1983-08-04
IE37511B1 (en) 1977-08-03
ES413639A1 (es) 1976-01-16
JPS497237A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-22
CS190406B2 (en) 1979-05-31
DK142750C (da) 1981-08-17
YU321279A (en) 1983-04-27
SE399064B (sv) 1978-01-30
RO70892A (ro) 1982-02-26
DE2317710A1 (de) 1973-10-18
BE798051A (fr) 1973-10-11
IL42016A0 (en) 1973-06-29
FR2182947B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-07-02

Similar Documents

Publication Publication Date Title
IL43795A (en) 3-aminoalkylamino-1-phenoxy-2-propanol derivatives
ZA741280B (en) Thiazole derivatives
MY7800381A (en) Dopamine derivatives
ZA733812B (en) Cysteine derivatives
IL41060A0 (en) Alpha-aryl-4-substituted piperidinoalkanol derivatives
CY992A (en) Benzocycloheptathiophene derivatives
ZA736059B (en) New quinoxaline-di-n-oxide derivatives
GB1402219A (en) Berbine derivatives
ZA728917B (en) Oxaziniondole-and thiaziniondole derivatives
IL43280A0 (en) Amidinourea derivatives
IL42943A (en) 16-methyl-prednisolone derivatives
PH10465A (en) Debenzazecine derivatives
IL41789A (en) Diphenylalkyllactamimide derivatives
KE2917A (en) New phenylformamidine derivatives
GB1405227A (en) Pheynlthioethyl-imidazole derivatives
ZA728875B (en) Pyrano-and thiopyranoindole derivatives
ZA734945B (en) New beta-aminoketone derivatives
IE38616L (en) Diphenylamine derivatives
HK380A (en) Benzoisoindoline derivatives
PH10653A (en) Indolylimidoylquinoline derivatives
PH10601A (en) Diaza-oxa-bicyclodecane derivatives
AU5872373A (en) Isoxolidine derivatives
AU5916873A (en) Cyclohexanepentol derivative
GB1404382A (en) Homopyrimidazole derivatives
AU5667373A (en) Benzodaizepine derivatives benzodaizepine derivatives